12-Aug-2015 | S | Natco Pharma Ltd has informed BSE that the Board of Directors of the Company at its meeting held on August 12, 2015, inter alia, has approved the following items and recommended to the members for their approval in the ensuing Annual General Meeting:
1. Sub-division of face value of equity shares of the Company from Rs. 10/- (rupees ten only) each to that of Rs. 2/- (rupees two only) each.
SUB. :- Sub Division of equity shares of Natco Pharma Limited. (Scrip Code 524816)
Trading Members of the Exchange are hereby informed that, Natco Pharma Ltd. has fixed the Record Date for the purpose of sub division of equity shares of the company.
DEMATERIALISED SECURITIES - ROLLING SETTLEMENT SEGMENT
COMPANY NAME & CODE
Natco Pharma Ltd.
(524816; 624816)
RECORD DATE
28/11/2015
PURPOSE
Sub Division of existing equity shares from every ONE equity share of Rs.10/- each into FIVE equity shares of Rs.2/- each.
SUB-DIVIDED PAID-UP VALUE
Rs.2/-
SUB-DIVIDED PAID-UP VALUE W.E.F.
26/11/2015 DR-164/2015- 2016
Note:-
i. Trading members are hereby informed that the transactions in the equity shares (physical) of the aforesaid company in the Exit-Route Scheme will be for Rs. 2/- paid up w.e.f. 26/11/2015.
ii. ISIN No. INE987B01018 of Rs.10/- paid up will not be valid for transactions done on the Exchange on or after 26/11/2015.
iii. The new ISIN Number for Rs.2/- paid up will be informed to the market by a separate notice.
(As Per BSE Notice Dated on 16/11/2015) | 28-Nov-2015 | |
14-Feb-2024 | D | outcome of Board Meeting | 26-Feb-2024 | |
14-Nov-2023 | D | Outcome of the Board Meeting
Declared second interim dividend of Rs.1.25 (Rupees one and twenty five paise only) (62.50 %) each per equity share of Rs.2/- (Rupees two only) each for the financial year 2023-24. The date for taking on record of its shareholders eligible for the purpose of payment ofsecond interim dividend i.e.,record date is fixed as Friday, the 24th day of November 2023. The payment of said interim dividend will start from 1st December 2023. | 24-Nov-2023 | |
09-Aug-2023 | D | Approved:-
1. Declared interim dividend of Rs.7/- (Rupees Seven only) (350 %) per equity share of Rs.2/- (Rupees two only) each for the financial year 2023-24. The date for taking on record of its shareholders eligible for the purpose of payment of interim dividend i.e., record date is fixed as Tuesday, the 22nd day of August 2023. The payment of said interim dividend will start from 30th August 2023. | 22-Aug-2023 | |
09-Feb-2023 | D | Board approved:-
1) Declared Third Interim Dividend of Rs.1.25 {one rupee twenty-five paise only i.e., 62.50%) each per equity share of Rs.2/- {Rupees two only) each for the financial year 2022-23. The date for taking on record of its shareholders eligible for the purpose of payment of 3rd' interim dividend i.e., record date is fixed as Tuesday, the 21' day of February, 2023. The payment of said interim dividend will be from l'' March, 2023.
2) The Board of Directors have approved to make the investment for an amount not exceeding Rs.13 Crores (6.68% of the capital on a fully diluted basis) in M/s. Redcliffe Hygiene Private Limited. | 21-Feb-2023 | |
10-Nov-2022 | D | Outcome of the Board Meeting held on 10-Nov-2022 to consider the unaudited financial Results for the quarter and half year ended 30th September 2022 and declared 2nd Interim Dividend of Rs.0.75 (i.e., 37.50%) per Equity shares of Rs.2/- each. | 21-Nov-2022 | |
09-Aug-2022 | D | Interim Dividend of Rs.3.50 per equity share of Rs.2/- each | 19-Aug-2022 | |
14-Feb-2022 | D | Natco Pharma Ltd has informed BSE that the Board of Directors of the Company at its meeting held on February 14, 2022, inter alia, has declared 3rd interim dividend of Rs. 2/- each per Equity share of Rs. 2/- each for the financial year 2021-22 (which is 100% on the nominal value of the equity share). The payment of said interim dividend will start from March 04, 2022. | 24-Feb-2022 | |
11-Nov-2021 | D | Unaudited Financial Results for the quarter and half year ended 30th September, 2021 | 23-Nov-2021 | |
12-Aug-2021 | D | Declared an Interim Dividend of Rs.2/- each for the Financial year 2021-22 | 24-Aug-2021 | |
11-Feb-2021 | D | Natco Pharma Ltd has informed BSE that the Board of Directors of the Company at its meeting held on February 11, 2021, inter alia, has declared 3rd interim dividend of Rs. 1/- (Rupees one only) each per Equity share of Rs. 2/- (Rupees two only) each for the financial. year 2020-21 (which is 50% on the nominal value of the equity share). | 22-Feb-2021 | |
12-Nov-2020 | D | Unaudited Financial Results for the Quarter and Half year ended 30th September, 2020 | 24-Nov-2020 | |
12-Aug-2020 | D | Natco Pharma Ltd has informed BSE that the Board of Directors of the Company at its meeting held on August 12, 2020, inter alia, have considered and approved the following :
- Declaration of interim dividend of Rs. 1.25 ps. per equity share of Rs. 2/- each for the financial year 2020-21. The said interim dividend pay-by-date is on or before August 31, 2020. | 21-Aug-2020 | |
17-Jun-2020 | D | Natco Pharma Ltd has informed BSE that the Board of Directors of the Company at its meeting held on June 17, 2020, inter alia, has considered and approved the following:
- Declaration of fourth (4th) interim dividend of Rs. 1/- per equity share of Rs .2/- each for the financial year 2019-20. The said interim dividend will be paid on or before July 05, 2020. | 26-Jun-2020 | |
12-Feb-2020 | D | The Board of Directors of the Company at their meeting held on 12/2/2020 have declared 3rd Interim Dividend of Rs.3.50 per Equity share of Rs.2/- each for the FY 2019-2020 | 24-Feb-2020 | |
12-Nov-2019 | D | Natco Pharma Ltd has informed BSE that the Board of Directors of the Company at its meeting held on November 12, 2019, inter alia, have considered and approved the following business:
- Declaration of second interim dividend of Rs. 1 (Rupees one only) per equity share of Rs. 2/- each for the financial year 2019-20. The said interim dividend pay-by-date is on or before November 29, 2019. | 21-Nov-2019 | |
09-Aug-2019 | D | Natco Pharma Ltd has informed BSE that the Board of Directors of the Company at their meeting held on August 09, 2019, inter alia, have considered and approved the following along with other items of business:
- Declaration of interim dividend of Rs. 1.25 ps. per equity share of Rs. 2/- each for the financial year 2019-20. The said interim dividend pay-by-date is on or before August 29, 2019. | 22-Aug-2019 | |
27-May-2019 | D | Results For the Financial Year 18-19 | 06-Jun-2019 | |
12-Feb-2019 | D | Natco Pharma Ltd has informed BSE that the Board of Directors of the Company at its meeting held on February 12, 2019, inter alia, has declared second interim dividend of Rs.3.50 ps. (Rupees three and paise fifty only) on each equity
share of face value Rs. 2/- (Rupees two only) each for the financial year 2018-2019.
The said interim dividend will be paid from February 26, 2019. | 21-Feb-2019 | |
08-Aug-2018 | D | Natco Pharma Ltd has informed BSE that the Board of Directors of the Company at its meeting held on August 08, 2018, inter alia, has approved the following :
- Declaration of an interim dividend of Rs. 1.50 ps. per equity share of Rs. 2/- each (75%) for the financial year 2018-19. The said interim dividend pay-by-date is on or before August 27, 2018. | 20-Aug-2018 | |
06-Feb-2018 | D | Natco Pharma Ltd has informed BSE that the Board of Directors of the Company at their meeting held on February 06, 2018, inter alia, have declared second interim dividend of Rs. 7/- (Rupees seven only) on each equity share of Rs. 2/- (Rupees two only) each for the year 2017-18 (which is 350% on the nominal value of the share). The payment of said interim dividend will start from February 22, 2018. | 15-Feb-2018 | |
07-Aug-2017 | D | Natco Pharma Ltd has informed BSE that the Board of Directors of the Company at their meeting held on August 07, 2017, inter alia , have approved the following :
Recommended payment of an interim dividend of Rs.1.25 ps. (62.5%) per equity share of Rs.2/- each for the financial year 2017-18. | 16-Aug-2017 | |
14-Feb-2017 | D | Natco Pharma Ltd has informed BSE that the Board of Directors of the Company at its meeting held on February 14, 2017,inter alia, has declared second interim dividend of Rs.6/- (Rupees six only) on each equity share of Rs.2/- (Rupees two only) each for the year 2016-17. | 23-Feb-2017 | |
09-Aug-2016 | D | Natco Pharma Ltd has informed BSE that the Board of Directors of the Company at its meeting held on August 09, 2016, inter alia, have transacted the following:
1. Recommended payment of an interim dividend of Rs. 0.75 ps. on each equity share of Rs. 2/- each for the year 2016-17. | 19-Aug-2016 | |
11-Feb-2016 | D | Natco Pharma Ltd has informed BSE that the Board of Directors of the Company at its meeting held on February 11, 2016, has recommended payment of an interim dividend of Rs. 1.25/- on each equity share of Rs. 2/- each for the year 2015-2016. | 22-Feb-2016 | |
11-Feb-2015 | D | Natco Pharma Ltd has informed BSE that the Board of Directors of the Company at its meeting held on February 11, 2015, inter alia, has recommended payment of an interim dividend of Rs. 5/- per equity share of Rs.10/- each for the year 2014-2015. | 24-Feb-2015 | |
13-Feb-2014 | D | Natco Pharma Ltd has informed BSE that the Board of Directors of the Company at its meeting held on February 13, 2014, inter alia, has considered and approved the following:
1. The Board also recommended payment of an interim dividend of Rs. 5/- per equity share of Rs. 10/- each for the year 2013-2014. | 24-Feb-2014 | |
13-Feb-2013 | D | Natco Pharma Ltd has informed BSE that the Board of Directors of the Company at its meeting held on February 13, 2013, inter alia, has recommended payment of an interim dividend of Rs. 4/- per equity share of Rs. 10/- each for the year
2012-2013. | 22-Feb-2013 | |
09-Feb-2012 | D | Natco Pharma Ltd has informed BSE that the Board of Directors of the Company at its meeting held on February 09, 2012, inter alia, has declared payment of an interim dividend of Rs. 3/- per equity share of Rs. 10/- each for the year 2011-2012. | 22-Feb-2012 | |
14-Feb-2011 | D | Natco Pharma Ltd has informed BSE that the Board of Directors of the Company at its meeting held on February 14, 2011, inter alia, has recommends payment of an interim dividend of Rs. 2/- per equity shares of Rs. 10/- each for the year 2010-2011. | 24-Feb-2011 | |
28-Jan-2010 | D | Natco Pharma Ltd has informed BSE that the Board of Directors of the Company at its meeting held on January 27, 2009, inter alia, has recommended payment of an Interim Dividend of Rs. 2 per equity share. | 05-Feb-2010 | |
25-May-2009 | D | Natco Pharma Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 25, 2009, inter alia, have declared an interim dividend of Rs 1.25 per share for the year 2008-09. | 04-Jun-2009 | |
25-Oct-2007 | D | Natco Pharma Ltd has informed BSE that the Board of Directors of the Company at its meeting held on October 25, 2007, inter alia, has declared an interim dividend of Rs 1.25 ps. per share for the year 2007-08. | 12-Nov-2007 | |
26-Oct-2006 | D | 12.5% Interim Dividend | 10-Nov-2006 | |
26-Oct-2006 | D | 12.5% Dividend | 10-Nov-2006 | |
14-Feb-2024 | BC | NATCO PHARMA LIMITED has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.
Details are as under:
Details
Reason Of Change | 01-Apr-2024 | |
09-Aug-2023 | BC | Approved:-
1. Declared interim dividend of Rs.7/- (Rupees Seven only) (350 %) per equity share of Rs.2/- (Rupees two only) each for the financial year 2023-24. The date for taking on record of its | 31-Mar-2024 | |
14-Nov-2023 | BC | Outcome of the Board Meeting
Declared second interim dividend of Rs.1.25 (Rupees one and twenty five paise only) (62.50 %) each per equity share of Rs.2/- (Rupees two only) each for the financial | 31-Mar-2024 | |
14-Feb-2024 | BC | outcome of Board Meeting | 31-Mar-2024 | |
22-Feb-2024 | BC | Notice of Postal Ballot dated February 14 2024
Copy of Newspaper Publication of Postal Ballot Notice
(As Per BSE Announcement Dated on 26/02/2024)
E-voting Results along with Scrutinizers Re | 26-Mar-2024 | |